Free Trial

IQVIA (IQV) Financials

IQVIA logo
$170.68 -1.70 (-0.99%)
Closing price 03:59 PM Eastern
Extended Trading
$170.00 -0.68 (-0.40%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for IQVIA

Annual Income Statements for IQVIA

This table shows IQVIA's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
387 72 1,277 259 191 279 966 1,091 1,358 1,373 1,360
Consolidated Net Income / (Loss)
388 87 1,296 284 227 308 971 1,091 1,358 1,373 1,361
Net Income / (Loss) Continuing Operations
388 87 1,296 284 227 308 971 1,091 1,358 1,373 1,361
Total Pre-Tax Income
539 416 294 328 352 373 1,128 1,363 1,459 1,669 1,591
Total Operating Income
646 576 665 741 777 731 1,393 1,799 1,977 2,202 2,182
Total Gross Profit
1,621 2,067 3,401 3,666 3,788 3,859 4,641 5,028 5,239 5,375 5,430
Total Revenue
5,737 6,815 9,702 10,412 11,088 11,359 13,874 14,410 14,984 15,405 16,310
Operating Revenue
5,737 6,815 9,702 10,412 11,088 11,359 13,874 14,410 14,984 15,405 16,310
Total Cost of Revenue
4,116 4,748 6,301 6,746 7,300 7,500 9,233 9,382 9,745 10,030 10,880
Operating Cost of Revenue
4,116 4,748 6,301 6,746 7,300 7,500 9,233 9,382 9,745 10,030 10,880
Total Operating Expenses
975 1,491 2,736 2,925 3,011 3,128 3,248 3,229 3,262 3,173 3,248
Selling, General & Admin Expense
815 1,016 1,622 1,716 1,734 1,789 1,964 2,071 2,053 1,992 1,999
Depreciation Expense
128 289 1,011 1,141 1,202 1,287 1,264 1,130 1,125 1,114 1,144
Restructuring Charge
30 158 63 68 75 52 20 28 84 67 105
Total Other Income / (Expense), net
-107 -160 -371 -413 -425 -358 -265 -436 -518 -533 -591
Interest Expense
109 175 365 416 471 429 401 416 678 670 735
Interest & Investment Income
4.00 4.00 7.00 8.00 9.00 6.00 6.00 13 36 47 45
Other Income / (Expense), net
-2.00 11 -13 -5.00 37 65 130 -33 124 90 99
Income Tax Expense
159 325 -992 59 116 72 163 260 101 301 252
Other Gains / (Losses), net
8.00 -4.00 10 15 -9.00 7.00 6.00 -12 0.00 5.00 22
Net Income / (Loss) Attributable to Noncontrolling Interest
1.00 15 19 25 36 29 5.00 - 0.00 0.00 1.00
Basic Earnings per Share
$3.15 $0.48 $5.86 $1.27 $0.98 $1.46 $5.05 $5.82 $7.39 $7.57 $7.91
Weighted Average Basic Shares Outstanding
123M 149.10M 217.80M 203.70M 195.10M 191.30M 191.40M 187.60M 183.80M 181.30M 171.90M
Diluted Earnings per Share
$3.08 $0.47 $5.74 $1.24 $0.96 $1.43 $4.95 $5.72 $7.29 $7.49 $7.84
Weighted Average Diluted Shares Outstanding
125.60M 152M 222.60M 208.20M 199.60M 195M 195M 190.60M 186.30M 183.40M 173.50M
Weighted Average Basic & Diluted Shares Outstanding
122.90M 149.40M 217.90M 203.90M 192.34M 191.28M 190.49M 185.72M 181.50M 176.10M 169.70M

Quarterly Income Statements for IQVIA

This table shows IQVIA's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
303 469 288 363 285 437 249 266 331 514 274
Consolidated Net Income / (Loss)
303 469 288 363 285 437 249 266 332 514 275
Net Income / (Loss) Continuing Operations
303 469 288 363 285 437 249 266 332 514 275
Total Pre-Tax Income
349 373 340 436 349 544 323 323 408 537 328
Total Operating Income
481 501 506 520 550 626 496 506 553 627 514
Total Gross Profit
1,310 1,390 1,293 1,326 1,378 1,378 1,298 1,323 1,373 1,436 1,355
Total Revenue
3,736 3,868 3,737 3,814 3,896 3,958 3,829 4,017 4,100 4,364 4,151
Operating Revenue
3,736 3,868 3,737 3,814 3,896 3,958 3,829 4,017 4,100 4,364 4,151
Total Cost of Revenue
2,426 2,478 2,444 2,488 2,518 2,580 2,531 2,694 2,727 2,928 2,796
Operating Cost of Revenue
2,426 2,478 2,444 2,488 2,518 2,580 2,531 2,694 2,727 2,928 2,796
Total Operating Expenses
829 889 787 806 828 752 802 817 820 809 841
Selling, General & Admin Expense
502 556 508 509 522 453 508 509 514 468 502
Depreciation Expense
297 316 264 269 278 303 265 276 286 317 288
Restructuring Charge
30 17 15 28 28 -4.00 29 32 20 24 51
Total Other Income / (Expense), net
-132 -128 -166 -84 -201 -82 -173 -183 -145 -90 -186
Interest Expense
181 187 166 163 170 171 169 182 189 195 192
Interest & Investment Income
14 12 11 12 13 11 11 10 13 11 10
Other Income / (Expense), net
35 47 -11 67 -44 78 -15 -11 31 94 -4.00
Income Tax Expense
51 -102 49 75 65 112 61 56 76 59 59
Other Gains / (Losses), net
5.00 -6.00 -3.00 2.00 1.00 5.00 -13 -1.00 0.00 36 6.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - 0.00 - 0.00 - 1.00 - 1.00
Basic Earnings per Share
$1.66 $2.56 $1.58 $1.99 $1.57 $2.43 $1.42 $1.55 $1.94 $3.00 $1.63
Weighted Average Basic Shares Outstanding
182.90M 183.80M 181.90M 182.20M 182.10M 181.30M 175.70M 171.80M 170.20M 171.90M 168.40M
Diluted Earnings per Share
$1.63 $2.54 $1.56 $1.97 $1.55 $2.41 $1.40 $1.54 $1.93 $2.97 $1.61
Weighted Average Diluted Shares Outstanding
185.50M 186.30M 184.30M 184.30M 184.20M 183.40M 177.40M 173.20M 171.70M 173.50M 169.80M
Weighted Average Basic & Diluted Shares Outstanding
182.50M 181.50M 182.20M 182.30M 181.50M 176.10M 173M 170M 170.30M 169.70M 166.90M

Annual Cash Flow Statements for IQVIA

This table details how cash moves in and out of IQVIA's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
110 221 -292 -68 -54 977 -448 -150 160 326 278
Net Cash From Operating Activities
476 860 970 1,254 1,417 1,959 2,942 2,260 2,149 2,716 2,654
Net Cash From Continuing Operating Activities
476 860 970 1,254 1,417 1,959 2,942 2,260 2,149 2,716 2,654
Net Income / (Loss) Continuing Operations
388 87 1,296 284 227 308 971 1,091 1,358 1,373 1,361
Consolidated Net Income / (Loss)
388 87 1,296 284 227 308 971 1,091 1,358 1,373 1,361
Depreciation Expense
128 289 1,011 1,141 1,202 1,287 1,264 1,130 1,125 1,114 1,144
Amortization Expense
17 33 12 11 13 18 17 15 18 21 23
Non-Cash Adjustments To Reconcile Net Income
-7.00 61 59 108 113 63 739 223 197 179 181
Changes in Operating Assets and Liabilities, net
-50 390 -1,408 -290 -138 283 -49 -199 -549 29 -55
Net Cash From Investing Activities
-67 1,731 -1,190 -810 -1,190 -796 -2,103 -2,006 -1,603 -1,444 -2,305
Net Cash From Continuing Investing Activities
-67 1,731 -1,190 -810 -1,190 -796 -2,103 -2,006 -1,603 -1,444 -2,305
Purchase of Property, Plant & Equipment
-78 -164 -369 -459 -582 -616 -640 -674 -649 -602 -603
Acquisitions
32 1,887 -854 -309 -588 -177 -1,458 -1,315 -876 -735 -1,714
Purchase of Investments
-23 -57 - -44 -3.00 1.00 -15 -25 -45 -132 -42
Sale of Property, Plant & Equipment
- - - - - - - 0.00 0.00 25 75
Sale and/or Maturity of Investments
0.00 41 17 - -22 -2.00 5.00 0.00 -38 -2.00 -20
Other Investing Activities, net
2.00 24 4.00 2.00 5.00 -2.00 5.00 8.00 5.00 2.00 -1.00
Net Cash From Financing Activities
-249 -2,284 -72 -452 -276 -217 -1,235 -329 -382 -878 -150
Net Cash From Continuing Financing Activities
-249 -2,284 -72 -452 -276 -217 -1,235 -329 -382 -878 -150
Repayment of Debt
-2,083 -1,958 -4,702 -3,083 -3,722 -2,532 -2,731 -2,664 -5,632 -1,133 -8,646
Repurchase of Common Equity
-515 -1,097 -2,620 -1,405 -949 -447 -406 -1,168 -992 -1,350 -1,244
Issuance of Debt
2,249 638 7,163 4,076 4,422 2,841 2,761 3,600 6,384 1,685 9,840
Other Financing Activities, net
39 36 87 -9.00 -9.00 -66 -101 -97 -142 -80 -100
Effect of Exchange Rate Changes
-50 -86 - -60 -5.00 31 -52 -75 -4.00 -68 79

Quarterly Cash Flow Statements for IQVIA

This table details how cash moves in and out of IQVIA's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-158 152 68 101 27 130 38 299 -225 166 -33
Net Cash From Operating Activities
583 747 522 588 721 885 568 443 908 735 618
Net Cash From Continuing Operating Activities
583 747 522 588 721 885 568 443 908 735 618
Net Income / (Loss) Continuing Operations
303 469 288 363 285 437 249 266 332 514 275
Consolidated Net Income / (Loss)
303 469 288 363 285 437 249 266 332 514 275
Depreciation Expense
297 316 264 269 278 303 265 276 286 317 288
Amortization Expense
5.00 5.00 5.00 6.00 5.00 5.00 5.00 6.00 6.00 6.00 6.00
Non-Cash Adjustments To Reconcile Net Income
47 36 47 46 36 50 86 44 51 - 77
Changes in Operating Assets and Liabilities, net
-69 -79 -82 -96 117 90 -37 -149 233 -102 -28
Net Cash From Investing Activities
-573 -212 -314 -221 -599 -310 -305 -346 -550 -1,104 -196
Net Cash From Continuing Investing Activities
-573 -212 -314 -221 -597 -312 -305 -346 -550 -1,104 -196
Purchase of Property, Plant & Equipment
-146 -179 -145 -143 -150 -164 -142 -151 -136 -174 -127
Acquisitions
-425 -7.00 -142 -79 -428 -86 -134 -181 -483 -916 -37
Purchase of Investments
-3.00 -25 -24 -24 49 -132 -32 -14 -21 6.00 -35
Sale and/or Maturity of Investments
- -2.00 -3.00 - -66 66 2.00 - 19 -22 1.00
Other Investing Activities, net
1.00 1.00 0.00 - -2.00 4.00 1.00 - -4.00 2.00 2.00
Net Cash From Financing Activities
-144 -420 -106 -260 -137 -375 -258 145 -572 535 -433
Net Cash From Continuing Financing Activities
-144 -420 -106 -260 -137 -375 -258 145 -572 535 -433
Repayment of Debt
-442 -3,311 -318 -353 -244 -218 -2,102 -1,784 -1,035 -3,725 -1,037
Repurchase of Common Equity
-144 -229 0.00 - -200 -1,150 -375 -657 - -212 -552
Issuance of Debt
450 3,125 275 100 310 1,000 2,260 2,600 500 4,480 1,200
Other Financing Activities, net
-8.00 -5.00 -63 -7.00 -3.00 -7.00 -41 -14 -37 -8.00 -44
Effect of Exchange Rate Changes
-24 37 -34 -6.00 - - 33 57 -11 - -22

Annual Balance Sheets for IQVIA

This table presents IQVIA's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
3,926 21,208 22,857 22,549 23,251 24,564 24,689 25,337 26,681 26,899 29,944
Total Current Assets
2,412 3,337 3,554 3,874 4,126 5,090 4,763 4,981 5,596 5,829 6,249
Cash & Equivalents
977 1,198 959 891 837 1,814 1,366 1,216 1,376 1,702 1,980
Short-Term Investments
0.00 40 46 47 62 88 111 93 120 141 161
Accounts Receivable
1,166 1,707 2,097 2,394 2,582 2,410 2,551 2,917 3,381 3,204 3,400
Prepaid Expenses
51 123 146 151 138 159 156 151 141 154 162
Current Deferred & Refundable Income Taxes
135 34 47 69 56 56 58 43 32 36 27
Other Current Assets
83 235 259 322 451 563 521 561 546 592 519
Plant, Property, & Equipment, net
188 406 440 434 458 482 497 532 523 535 533
Total Noncurrent Assets
1,326 17,465 18,863 18,241 18,667 18,992 19,429 19,824 20,562 20,535 23,162
Long-Term Investments
85 82 78 142 152 162 164 162 239 374 432
Goodwill
720 10,727 11,850 11,800 12,159 12,654 13,301 13,921 14,567 14,710 16,616
Intangible Assets
368 6,390 6,591 5,951 5,514 5,205 4,943 4,820 4,839 4,499 4,962
Noncurrent Deferred & Refundable Income Taxes
43 89 109 109 119 114 124 118 166 194 357
Other Noncurrent Operating Assets
110 177 235 239 723 857 897 803 751 758 795
Total Liabilities & Shareholders' Equity
3,926 21,208 22,857 22,549 23,251 24,564 24,689 25,337 26,681 26,899 29,944
Total Liabilities
4,262 12,348 14,613 15,595 16,988 18,284 18,647 19,572 20,569 20,832 23,314
Total Current Liabilities
1,594 2,705 3,156 3,534 3,945 4,558 5,241 5,578 6,491 6,957 8,338
Short-Term Debt
49 92 103 100 100 149 91 152 718 1,145 1,840
Accounts Payable
145 250 322 2,295 2,512 2,813 2,981 3,316 3,564 3,684 3,751
Current Deferred Revenue
585 774 985 - - 1,252 1,825 1,797 1,799 1,779 2,118
Current Deferred & Payable Income Tax Liabilities
35 76 72 100 108 102 137 161 116 156 140
Other Current Liabilities
19 20 10 1,039 1,225 242 207 152 294 193 489
Total Noncurrent Liabilities
2,668 9,643 11,457 12,061 13,043 13,726 13,406 13,994 14,078 13,875 14,976
Long-Term Debt
2,419 7,108 10,122 10,907 11,545 12,384 12,034 12,595 12,955 12,838 13,884
Noncurrent Deferred & Payable Income Tax Liabilities
66 2,133 895 736 646 338 410 464 202 196 179
Other Noncurrent Operating Liabilities
183 402 440 418 852 1,004 962 935 921 841 913
Commitments & Contingencies
0.00 0.00 0.00 0.00 - - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-336 8,860 8,244 6,954 6,263 6,280 6,042 5,765 6,112 6,067 6,630
Total Preferred & Common Equity
-564 8,633 7,995 6,714 6,003 6,001 6,042 5,765 6,112 6,067 6,503
Total Common Equity
-564 8,633 7,995 6,714 6,003 6,001 6,042 5,765 6,112 6,067 6,503
Common Stock
9.00 10,602 10,782 10,901 11,049 11,095 10,777 10,898 11,028 11,143 11,378
Retained Earnings
-462 -399 538 807 998 1,277 2,243 3,334 4,692 6,065 7,425
Treasury Stock
0.00 -1,000 -3,374 -4,770 -5,733 -6,166 -6,572 -7,740 -8,741 -10,103 -11,357
Accumulated Other Comprehensive Income / (Loss)
-111 -570 49 -224 -311 -205 -406 -727 -867 -1,038 -943
Noncontrolling Interest
228 227 249 240 260 279 - - - 0.00 127

Quarterly Balance Sheets for IQVIA

This table presents IQVIA's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
26,036 25,977 26,681 26,574 26,398 27,180 26,899 27,322 28,632 28,727 29,675
Total Current Assets
5,329 5,208 5,596 5,651 5,622 5,632 5,829 5,911 6,345 5,979 6,220
Cash & Equivalents
1,382 1,224 1,376 1,444 1,545 1,572 1,702 1,740 2,039 1,814 1,947
Short-Term Investments
110 108 120 131 133 140 141 136 149 158 156
Accounts Receivable
3,139 3,227 3,381 3,426 3,255 3,196 3,204 3,268 3,344 3,269 3,346
Prepaid Expenses
179 177 141 173 191 195 154 166 200 177 167
Current Deferred & Refundable Income Taxes
45 49 32 35 41 54 36 43 62 45 29
Other Current Assets
474 423 546 442 457 475 592 558 551 516 575
Plant, Property, & Equipment, net
510 498 523 513 503 513 535 533 536 525 516
Total Noncurrent Assets
20,197 20,271 20,562 20,410 20,273 21,035 20,535 20,878 21,751 22,223 22,939
Long-Term Investments
208 214 239 263 287 320 374 383 406 405 452
Goodwill
14,178 14,288 14,567 14,516 14,477 15,091 14,710 15,027 15,611 15,948 16,544
Intangible Assets
4,942 4,907 4,839 4,725 4,608 4,734 4,499 4,503 4,596 4,707 4,803
Noncurrent Deferred & Refundable Income Taxes
115 111 166 152 158 164 194 245 345 390 358
Other Noncurrent Operating Assets
754 751 751 754 743 726 758 720 793 773 782
Total Liabilities & Shareholders' Equity
26,036 25,977 26,681 26,574 26,398 27,180 26,899 27,322 28,632 28,727 29,675
Total Liabilities
20,288 20,172 20,569 20,230 19,684 20,213 20,832 21,337 22,846 22,439 23,326
Total Current Liabilities
6,543 6,589 6,491 6,448 6,620 6,992 6,957 7,179 7,572 8,508 8,329
Short-Term Debt
1,344 1,309 718 717 1,167 1,219 1,145 1,222 1,313 2,164 1,844
Accounts Payable
3,007 3,133 3,564 3,455 3,313 3,434 3,684 3,559 3,399 3,550 3,639
Current Deferred Revenue
1,844 1,838 1,799 1,914 1,811 1,824 1,779 1,940 2,123 2,160 2,261
Current Deferred & Payable Income Tax Liabilities
208 172 116 155 185 161 156 139 124 119 172
Other Current Liabilities
140 137 294 207 144 354 193 319 613 515 413
Total Noncurrent Liabilities
13,745 13,583 14,078 13,782 13,064 13,221 13,875 14,158 15,274 13,931 14,997
Long-Term Debt
12,433 12,322 12,955 12,819 12,091 12,293 12,838 13,108 14,177 12,793 13,989
Noncurrent Deferred & Payable Income Tax Liabilities
367 365 202 164 149 128 196 197 216 207 159
Other Noncurrent Operating Liabilities
945 896 921 799 824 800 841 853 881 931 849
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5,748 5,805 6,112 6,344 6,714 6,967 6,067 5,985 5,786 6,288 6,349
Total Preferred & Common Equity
5,748 5,805 6,112 6,344 6,714 6,967 6,067 5,977 5,778 6,160 6,221
Total Common Equity
5,748 5,805 6,112 6,344 6,714 6,967 6,067 5,977 5,778 6,160 6,221
Common Stock
10,952 10,994 11,028 11,016 11,061 11,106 11,143 11,173 11,225 11,321 11,404
Retained Earnings
3,920 4,223 4,692 4,980 5,343 5,628 6,065 6,314 6,580 6,911 7,699
Treasury Stock
-8,364 -8,509 -8,741 -8,741 -8,741 -8,941 -10,103 -10,532 -11,145 -11,144 -11,914
Accumulated Other Comprehensive Income / (Loss)
-760 -903 -867 -911 -949 -826 -1,038 -978 -882 -928 -968
Noncontrolling Interest
- - - - - - - 8.00 8.00 128 128

Annual Metrics And Ratios for IQVIA

This table displays calculated financial ratios and metrics derived from IQVIA's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.07% 18.79% 42.36% 7.32% 6.49% 2.44% 22.14% 3.86% 3.98% 2.81% 5.87%
EBITDA Growth
8.68% 15.21% 84.27% 12.72% 7.47% 3.55% 33.46% 3.82% 11.44% 5.64% 0.61%
EBIT Growth
7.69% -8.85% 11.07% 12.88% 10.60% -2.21% 91.33% 15.96% 18.97% 9.09% -0.48%
NOPAT Growth
9.87% -72.33% 2,208.58% -79.11% -14.28% 13.24% 102.02% 22.16% 26.40% -1.92% 1.75%
Net Income Growth
8.68% -77.58% 1,389.66% -78.09% -20.07% 35.68% 215.26% 12.36% 24.47% 1.10% -0.87%
EPS Growth
13.24% -84.74% 1,121.28% -78.40% -22.58% 48.96% 246.15% 15.56% 27.45% 2.74% 4.67%
Operating Cash Flow Growth
9.93% 80.67% 12.79% 29.28% 13.00% 38.25% 50.18% -23.18% -4.91% 26.38% -2.28%
Free Cash Flow Firm Growth
-90.64% -47,438.45% 101.94% 323.39% -51.03% 28.07% 102.71% -33.50% -11.66% 143.26% -105.52%
Invested Capital Growth
66.36% 1,277.57% 17.95% -2.90% -0.14% -0.64% -1.33% 3.12% 5.92% -1.20% 10.92%
Revenue Q/Q Growth
1.96% 12.44% 2.60% 1.63% 1.90% 3.68% 2.50% 0.72% 0.87% 0.59% 2.55%
EBITDA Q/Q Growth
4.18% 10.48% 6.21% 5.42% 0.79% 6.27% 3.16% 0.97% 3.54% 4.35% 0.94%
EBIT Q/Q Growth
4.25% -13.32% 5.33% 12.37% -0.49% 13.07% 12.56% -3.71% 7.74% 7.30% 0.75%
NOPAT Q/Q Growth
1.58% -73.67% 2,968.26% -81.17% -18.70% 34.75% 18.72% -5.12% 21.63% -7.74% 4.06%
Net Income Q/Q Growth
5.10% -78.87% 2,845.45% -77.15% -19.79% 55.56% 24.01% -7.70% 21.68% -2.28% 6.00%
EPS Q/Q Growth
5.12% -85.54% 791.57% -77.58% -21.31% 58.89% 25.63% -6.69% 22.32% -1.71% 7.69%
Operating Cash Flow Q/Q Growth
-9.61% 38.79% -18.07% 17.20% 13.27% 9.32% -1.93% -5.52% 9.53% 5.35% -5.35%
Free Cash Flow Firm Q/Q Growth
-71.78% -2,426.06% 101.76% -49.43% -34.64% 22.27% -4.08% -40.24% 661.18% 44.48% -108.31%
Invested Capital Q/Q Growth
-5.89% 1,326.64% 8.40% -1.08% -0.09% 0.05% 1.58% 5.00% 0.89% -3.33% 4.84%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
28.26% 30.33% 35.05% 35.21% 34.16% 33.97% 33.45% 34.89% 34.96% 34.89% 33.29%
EBITDA Margin
13.75% 13.34% 17.26% 18.13% 18.30% 18.50% 20.21% 20.20% 21.65% 22.25% 21.14%
Operating Margin
11.26% 8.45% 6.85% 7.12% 7.01% 6.44% 10.04% 12.48% 13.19% 14.29% 13.38%
EBIT Margin
11.23% 8.61% 6.72% 7.07% 7.34% 7.01% 10.98% 12.26% 14.02% 14.88% 13.99%
Profit (Net Income) Margin
6.76% 1.28% 13.36% 2.73% 2.05% 2.71% 7.00% 7.57% 9.06% 8.91% 8.34%
Tax Burden Percent
71.99% 20.91% 440.82% 86.59% 64.49% 82.57% 86.08% 80.04% 93.08% 82.26% 85.54%
Interest Burden Percent
83.70% 70.87% 45.09% 44.57% 43.24% 46.86% 74.06% 77.18% 69.44% 72.82% 69.75%
Effective Tax Rate
29.50% 78.13% -337.42% 17.99% 32.95% 19.30% 14.45% 19.08% 6.92% 18.03% 15.84%
Return on Invested Capital (ROIC)
53.17% 1.59% 18.11% 3.55% 3.09% 3.51% 7.16% 8.67% 10.49% 10.06% 9.76%
ROIC Less NNEP Spread (ROIC-NNEP)
48.27% 0.52% -3.36% 0.15% 0.22% 0.83% 5.06% 5.32% 6.33% 6.42% 5.95%
Return on Net Nonoperating Assets (RNNOA)
-127.78% 0.45% -2.95% 0.19% 0.35% 1.40% 8.60% 9.81% 12.38% 12.49% 11.67%
Return on Equity (ROE)
-74.61% 2.04% 15.15% 3.74% 3.44% 4.91% 15.76% 18.48% 22.87% 22.55% 21.44%
Cash Return on Invested Capital (CROIC)
3.34% -171.33% 1.64% 6.49% 3.23% 4.15% 8.50% 5.61% 4.74% 11.27% -0.59%
Operating Return on Assets (OROA)
17.83% 4.67% 2.96% 3.24% 3.55% 3.33% 6.18% 7.06% 8.08% 8.56% 8.03%
Return on Assets (ROA)
10.75% 0.69% 5.88% 1.25% 0.99% 1.29% 3.94% 4.36% 5.22% 5.13% 4.79%
Return on Common Equity (ROCE)
-90.98% 1.93% 14.73% 3.62% 3.31% 4.70% 15.40% 18.48% 22.87% 22.55% 21.22%
Return on Equity Simple (ROE_SIMPLE)
-68.79% 1.01% 16.21% 4.23% 3.78% 5.13% 16.07% 18.92% 22.22% 22.63% 0.00%
Net Operating Profit after Tax (NOPAT)
455 126 2,909 608 521 590 1,192 1,456 1,840 1,805 1,836
NOPAT Margin
7.94% 1.85% 29.98% 5.84% 4.70% 5.19% 8.59% 10.10% 12.28% 11.72% 11.26%
Net Nonoperating Expense Percent (NNEP)
4.90% 1.07% 21.47% 3.40% 2.86% 2.68% 2.11% 3.35% 4.15% 3.64% 3.82%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 7.86% 9.30% 9.00% 8.22%
Cost of Revenue to Revenue
71.74% 69.67% 64.95% 64.79% 65.84% 66.03% 66.55% 65.11% 65.04% 65.11% 66.71%
SG&A Expenses to Revenue
14.21% 14.91% 16.72% 16.48% 15.64% 15.75% 14.16% 14.37% 13.70% 12.93% 12.26%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
16.99% 21.88% 28.20% 28.09% 27.16% 27.54% 23.41% 22.41% 21.77% 20.60% 19.91%
Earnings before Interest and Taxes (EBIT)
644 587 652 736 814 796 1,523 1,766 2,101 2,292 2,281
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
789 909 1,675 1,888 2,029 2,101 2,804 2,911 3,244 3,427 3,448
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 2.17 2.59 3.50 4.99 5.72 8.92 6.60 6.91 5.88 5.90
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.47 2.75 2.13 2.26 2.70 3.02 3.89 2.64 2.82 2.32 2.35
Price to Earnings (P/E)
21.84 260.03 16.20 90.74 156.97 123.12 55.80 34.88 31.09 25.98 28.23
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.58% 0.38% 6.17% 1.10% 0.64% 0.81% 1.79% 2.87% 3.22% 3.85% 3.54%
Enterprise Value to Invested Capital (EV/IC)
9.43 1.68 1.73 1.99 2.42 2.69 3.90 2.89 3.00 2.66 2.61
Enterprise Value to Revenue (EV/Rev)
1.76 3.64 3.10 3.23 3.68 3.97 4.64 3.42 3.61 3.08 3.17
Enterprise Value to EBITDA (EV/EBITDA)
12.78 27.31 17.96 17.83 20.13 21.47 22.96 16.95 16.70 13.84 14.98
Enterprise Value to EBIT (EV/EBIT)
15.66 42.30 46.13 45.75 50.17 56.66 42.27 27.93 25.78 20.69 22.65
Enterprise Value to NOPAT (EV/NOPAT)
22.14 197.06 10.34 55.40 78.39 76.45 54.03 33.89 29.44 26.28 28.13
Enterprise Value to Operating Cash Flow (EV/OCF)
21.19 28.87 31.01 26.85 28.82 23.02 21.88 21.83 25.20 17.46 19.47
Enterprise Value to Free Cash Flow (EV/FCFF)
352.51 0.00 114.45 30.26 74.93 64.62 45.51 52.43 65.17 23.46 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-7.35 0.81 1.24 1.58 1.86 2.00 2.01 2.21 2.24 2.30 2.37
Long-Term Debt to Equity
-7.20 0.80 1.23 1.57 1.84 1.97 1.99 2.18 2.12 2.12 2.09
Financial Leverage
-2.65 0.85 0.88 1.25 1.55 1.68 1.70 1.84 1.95 1.95 1.96
Leverage Ratio
-6.94 2.95 2.58 2.99 3.47 3.81 4.00 4.24 4.38 4.40 4.48
Compound Leverage Factor
-5.81 2.09 1.16 1.33 1.50 1.79 2.96 3.27 3.04 3.20 3.12
Debt to Total Capital
115.76% 44.83% 55.36% 61.28% 65.03% 66.62% 66.74% 68.86% 69.11% 69.74% 70.34%
Short-Term Debt to Total Capital
2.30% 0.57% 0.56% 0.56% 0.56% 0.79% 0.50% 0.82% 3.63% 5.71% 8.23%
Long-Term Debt to Total Capital
113.46% 44.26% 54.81% 60.73% 64.47% 65.83% 66.24% 68.04% 65.48% 64.03% 62.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
10.69% 1.41% 1.35% 1.34% 1.45% 1.48% 0.00% 0.00% 0.00% 0.00% 0.57%
Common Equity to Total Capital
-26.45% 53.75% 43.29% 37.38% 33.52% 31.90% 33.26% 31.14% 30.89% 30.26% 29.09%
Debt to EBITDA
3.13 7.92 6.10 5.83 5.74 5.97 4.32 4.38 4.21 4.08 4.56
Net Debt to EBITDA
1.78 6.47 5.46 5.26 5.22 4.98 3.74 3.87 3.68 3.43 3.81
Long-Term Debt to EBITDA
3.07 7.82 6.04 5.78 5.69 5.89 4.29 4.33 3.99 3.75 4.03
Debt to NOPAT
5.42 57.14 3.52 18.11 22.35 21.25 10.17 8.76 7.43 7.75 8.56
Net Debt to NOPAT
3.09 46.67 3.14 16.34 20.34 17.75 8.80 7.75 6.49 6.52 7.16
Long-Term Debt to NOPAT
5.31 56.41 3.48 17.95 22.16 20.99 10.10 8.65 7.04 7.11 7.56
Altman Z-Score
3.28 1.33 1.42 1.54 1.72 1.80 2.60 2.12 2.26 2.15 2.05
Noncontrolling Interest Sharing Ratio
-21.93% 5.34% 2.78% 3.22% 3.78% 4.30% 2.26% 0.00% 0.00% 0.00% 1.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.51 1.23 1.13 1.10 1.05 1.12 0.91 0.89 0.86 0.84 0.75
Quick Ratio
1.34 1.09 0.98 0.94 0.88 0.95 0.77 0.76 0.75 0.73 0.66
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
29 -13,544 263 1,113 545 698 1,415 941 831 2,022 -112
Operating Cash Flow to CapEx
610.26% 524.39% 262.87% 273.20% 243.47% 318.02% 459.69% 335.31% 331.12% 470.71% 502.65%
Free Cash Flow to Firm to Interest Expense
0.26 -77.39 0.72 2.67 1.16 1.63 3.53 2.26 1.23 3.02 -0.15
Operating Cash Flow to Interest Expense
4.37 4.91 2.66 3.01 3.01 4.57 7.34 5.43 3.17 4.05 3.61
Operating Cash Flow Less CapEx to Interest Expense
3.65 3.98 1.65 1.91 1.77 3.13 5.74 3.81 2.21 3.19 2.89
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.59 0.54 0.44 0.46 0.48 0.48 0.56 0.58 0.58 0.58 0.57
Accounts Receivable Turnover
5.36 4.74 5.10 4.64 4.46 4.55 5.59 5.27 4.76 4.68 4.94
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
30.33 22.95 22.94 23.83 24.86 24.17 28.34 28.01 28.41 29.12 30.54
Accounts Payable Turnover
32.44 24.04 22.03 5.16 3.04 2.82 3.19 2.98 2.83 2.77 2.93
Days Sales Outstanding (DSO)
68.12 76.94 71.56 78.72 81.90 80.20 65.26 69.25 76.71 78.01 73.90
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
11.25 15.18 16.57 70.80 120.18 129.58 114.52 122.49 128.85 131.88 124.71
Cash Conversion Cycle (CCC)
56.86 61.75 54.99 7.92 -38.27 -49.37 -49.27 -53.24 -52.14 -53.87 -50.82
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,070 14,740 17,386 16,881 16,857 16,749 16,526 17,041 18,050 17,833 19,781
Invested Capital Turnover
6.70 0.86 0.60 0.61 0.66 0.68 0.83 0.86 0.85 0.86 0.87
Increase / (Decrease) in Invested Capital
427 13,670 2,646 -505 -24 -108 -223 515 1,009 -217 1,948
Enterprise Value (EV)
10,086 24,829 30,079 33,669 40,835 45,100 64,384 49,332 54,165 47,433 51,665
Market Capitalization
8,452 18,722 20,688 23,502 29,981 34,352 53,900 38,056 42,227 35,667 38,387
Book Value per Share
($4.58) $35.07 $37.83 $33.19 $30.94 $31.30 $31.63 $31.04 $33.49 $33.43 $38.19
Tangible Book Value per Share
($13.42) ($34.46) ($49.43) ($54.56) ($60.14) ($61.85) ($63.87) ($69.86) ($72.84) ($72.41) ($88.52)
Total Capital
2,132 16,060 18,469 17,961 17,908 18,813 18,167 18,512 19,785 20,050 22,354
Total Debt
2,468 7,200 10,225 11,007 11,645 12,533 12,125 12,747 13,673 13,983 15,724
Total Long-Term Debt
2,419 7,108 10,122 10,907 11,545 12,384 12,034 12,595 12,955 12,838 13,884
Net Debt
1,406 5,880 9,142 9,927 10,594 10,469 10,484 11,276 11,938 11,766 13,151
Capital Expenditures (CapEx)
78 164 369 459 582 616 640 674 649 577 528
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-110 -514 -504 -498 -618 -1,221 -1,864 -1,754 -1,673 -1,826 -2,390
Debt-free Net Working Capital (DFNWC)
867 724 501 440 281 681 -387 -445 -177 17 -249
Net Working Capital (NWC)
818 632 398 340 181 532 -478 -597 -895 -1,128 -2,089
Net Nonoperating Expense (NNE)
67 39 1,613 324 294 282 221 365 482 432 475
Net Nonoperating Obligations (NNO)
1,406 5,880 9,142 9,927 10,594 10,469 10,484 11,276 11,938 11,766 13,151
Total Depreciation and Amortization (D&A)
145 322 1,023 1,152 1,215 1,305 1,281 1,145 1,143 1,135 1,167
Debt-free, Cash-free Net Working Capital to Revenue
-1.92% -7.54% -5.19% -4.78% -5.57% -10.75% -13.44% -12.17% -11.17% -11.85% -14.65%
Debt-free Net Working Capital to Revenue
15.11% 10.62% 5.16% 4.23% 2.53% 6.00% -2.79% -3.09% -1.18% 0.11% -1.53%
Net Working Capital to Revenue
14.26% 9.27% 4.10% 3.27% 1.63% 4.68% -3.45% -4.14% -5.97% -7.32% -12.81%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.15 $0.77 $6.01 $1.27 $0.98 $1.46 $5.05 $5.82 $7.39 $7.57 $7.91
Adjusted Weighted Average Basic Shares Outstanding
123.04M 149.10M 217.80M 203.70M 195.10M 191.30M 191.40M 187.60M 183.80M 181.30M 171.90M
Adjusted Diluted Earnings per Share
$3.08 $0.76 $5.88 $1.24 $0.96 $1.43 $4.95 $5.72 $7.29 $7.49 $7.84
Adjusted Weighted Average Diluted Shares Outstanding
125.63M 152M 222.60M 208.20M 199.60M 195M 195M 190.60M 186.30M 183.40M 173.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
119.38M 235.72M 208.25M 197.60M 192.34M 191.28M 190.49M 185.72M 181.50M 176.10M 169.70M
Normalized Net Operating Profit after Tax (NOPAT)
478 533 538 663 571 632 1,209 1,478 1,918 1,860 1,925
Normalized NOPAT Margin
8.33% 7.83% 5.54% 6.37% 5.15% 5.56% 8.71% 10.26% 12.80% 12.07% 11.80%
Pre Tax Income Margin
9.40% 6.10% 3.03% 3.15% 3.17% 3.28% 8.13% 9.46% 9.74% 10.83% 9.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
5.91 3.35 1.79 1.77 1.73 1.86 3.80 4.25 3.10 3.42 3.10
NOPAT to Interest Expense
4.18 0.72 7.97 1.46 1.11 1.38 2.97 3.50 2.71 2.69 2.50
EBIT Less CapEx to Interest Expense
5.19 2.42 0.78 0.67 0.49 0.42 2.20 2.63 2.14 2.56 2.39
NOPAT Less CapEx to Interest Expense
3.46 -0.22 6.96 0.36 -0.13 -0.06 1.38 1.88 1.76 1.83 1.78
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.77% 0.00% 0.00% 10.92% 7.93% 4.22% 78.06% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
133.51% 1,260.92% 202.16% 505.63% 425.99% 149.35% 119.88% 107.06% 73.05% 98.32% 91.40%

Quarterly Metrics And Ratios for IQVIA

This table displays calculated financial ratios and metrics derived from IQVIA's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 169,700,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 169,700,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.61
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.88% 3.45% 2.33% 2.31% 4.28% 2.33% 2.46% 5.32% 5.24% 10.26% 8.41%
EBITDA Growth
14.25% 14.64% 1.33% 7.35% -3.55% 16.46% -1.70% -9.86% 11.03% 3.16% 7.06%
EBIT Growth
11.21% 38.04% -0.40% 8.70% -1.94% 28.47% -2.83% -15.67% 15.42% 2.41% 6.03%
NOPAT Growth
8.02% 103.93% 14.38% 4.80% 8.97% -22.08% -7.10% -2.85% 0.54% 12.27% 4.78%
Net Income Growth
7.07% 106.61% -0.35% 22.22% -5.94% -6.82% -13.54% -26.72% 16.49% 17.62% 10.44%
EPS Growth
9.40% 109.92% 1.96% 23.90% -4.91% -5.12% -10.26% -21.83% 24.52% 23.24% 15.00%
Operating Cash Flow Growth
-32.45% 33.39% 25.18% 46.27% 23.67% 18.47% 8.81% -24.66% 25.94% -16.95% 8.80%
Free Cash Flow Firm Growth
-397.53% -83.52% -920.90% 125.57% 91.25% 292.49% 229.48% -203.29% 126.49% -294.63% -396.00%
Invested Capital Growth
10.23% 5.92% 4.23% 1.02% 3.11% -1.20% 0.08% 3.75% 2.28% 10.92% 8.70%
Revenue Q/Q Growth
0.21% 3.53% -3.39% 2.06% 2.15% 1.59% -3.26% 4.91% 2.07% 6.44% -4.88%
EBITDA Q/Q Growth
1.87% 6.23% -12.08% 12.83% -8.47% 28.26% -25.79% 3.46% 12.74% 19.18% -22.99%
EBIT Q/Q Growth
-4.44% 6.20% -9.67% 18.59% -13.80% 39.13% -31.68% 2.91% 17.98% 23.46% -29.26%
NOPAT Q/Q Growth
-0.03% 55.34% -32.12% -0.58% 3.95% 11.07% -19.07% 3.96% 7.58% 24.03% -24.47%
Net Income Q/Q Growth
2.02% 54.79% -38.59% 26.04% -21.49% 53.33% -43.02% 6.83% 24.81% 54.82% -46.50%
EPS Q/Q Growth
2.52% 55.83% -38.58% 26.28% -21.32% 55.48% -41.91% 10.00% 25.32% 53.89% -45.79%
Operating Cash Flow Q/Q Growth
45.02% 28.13% -30.12% 12.64% 22.62% 22.75% -35.82% -22.01% 104.97% -19.05% -15.92%
Free Cash Flow Firm Q/Q Growth
-28.61% 70.33% 19.16% 182.87% -144.03% 752.55% -45.62% -166.11% 111.29% -4,894.34% 17.30%
Invested Capital Q/Q Growth
0.36% 0.89% -0.04% -0.19% 2.44% -3.33% 1.25% 3.47% 1.00% 4.84% -0.78%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
35.06% 35.94% 34.60% 34.77% 35.37% 34.82% 33.90% 32.94% 33.49% 32.91% 32.64%
EBITDA Margin
21.90% 22.47% 20.44% 22.60% 20.25% 25.57% 19.61% 19.34% 21.37% 23.92% 19.37%
Operating Margin
12.87% 12.95% 13.54% 13.63% 14.12% 15.82% 12.95% 12.60% 13.49% 14.37% 12.38%
EBIT Margin
13.81% 14.17% 13.25% 15.39% 12.99% 17.79% 12.56% 12.32% 14.24% 16.52% 12.29%
Profit (Net Income) Margin
8.11% 12.13% 7.71% 9.52% 7.32% 11.04% 6.50% 6.62% 8.10% 11.78% 6.62%
Tax Burden Percent
86.82% 125.74% 84.71% 83.26% 81.66% 80.33% 77.09% 82.35% 81.37% 95.72% 83.84%
Interest Burden Percent
67.64% 68.07% 68.69% 74.28% 68.97% 77.27% 67.15% 65.25% 69.86% 74.48% 64.31%
Effective Tax Rate
14.61% -27.35% 14.41% 17.20% 18.62% 20.59% 18.89% 17.34% 18.63% 10.99% 17.99%
Return on Invested Capital (ROIC)
9.57% 14.09% 9.88% 9.55% 9.68% 10.78% 9.02% 8.91% 9.36% 11.09% 8.96%
ROIC Less NNEP Spread (ROIC-NNEP)
8.63% 12.63% 8.62% 8.97% 8.30% 10.28% 7.73% 7.65% 8.37% 10.74% 7.81%
Return on Net Nonoperating Assets (RNNOA)
17.78% 24.69% 16.21% 16.82% 15.32% 20.00% 14.91% 14.81% 15.20% 21.07% 16.05%
Return on Equity (ROE)
27.36% 38.77% 26.09% 26.37% 25.00% 30.79% 23.93% 23.72% 24.56% 32.16% 25.01%
Cash Return on Invested Capital (CROIC)
-0.87% 4.74% 6.61% 9.65% 7.70% 11.27% 9.77% 5.93% 7.20% -0.59% 1.51%
Operating Return on Assets (OROA)
8.17% 8.16% 7.63% 8.90% 7.48% 10.23% 7.22% 7.03% 8.10% 9.48% 7.17%
Return on Assets (ROA)
4.80% 6.99% 4.44% 5.50% 4.22% 6.35% 3.74% 3.78% 4.61% 6.76% 3.87%
Return on Common Equity (ROCE)
27.36% 38.77% 26.09% 26.37% 25.00% 30.79% 23.91% 23.70% 24.32% 31.84% 24.74%
Return on Equity Simple (ROE_SIMPLE)
19.22% 0.00% 21.39% 21.19% 20.17% 0.00% 22.32% 21.41% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
411 638 433 431 448 497 402 418 450 558 422
NOPAT Margin
10.99% 16.49% 11.59% 11.29% 11.49% 12.56% 10.51% 10.41% 10.98% 12.79% 10.16%
Net Nonoperating Expense Percent (NNEP)
0.94% 1.46% 1.26% 0.58% 1.38% 0.51% 1.29% 1.26% 0.98% 0.35% 1.16%
Return On Investment Capital (ROIC_SIMPLE)
- 3.22% - - - 2.48% 1.98% 1.97% 2.12% 2.50% 1.90%
Cost of Revenue to Revenue
64.94% 64.06% 65.40% 65.23% 64.63% 65.18% 66.10% 67.07% 66.51% 67.09% 67.36%
SG&A Expenses to Revenue
13.44% 14.37% 13.59% 13.35% 13.40% 11.45% 13.27% 12.67% 12.54% 10.72% 12.09%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
22.19% 22.98% 21.06% 21.13% 21.25% 19.00% 20.95% 20.34% 20.00% 18.54% 20.26%
Earnings before Interest and Taxes (EBIT)
516 548 495 587 506 704 481 495 584 721 510
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
818 869 764 862 789 1,012 751 777 876 1,044 804
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.21 6.91 7.28 5.74 6.20 5.88 5.19 4.72 5.24 5.90 4.65
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.43 2.82 3.06 2.54 2.82 2.32 2.00 1.74 2.03 2.35 1.74
Price to Earnings (P/E)
32.28 31.09 34.01 27.07 30.75 25.98 23.27 22.04 25.17 28.23 20.90
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
3.10% 3.22% 2.94% 3.69% 3.25% 3.85% 4.30% 4.54% 3.97% 3.54% 4.79%
Enterprise Value to Invested Capital (EV/IC)
2.69 3.00 3.21 2.77 2.96 2.66 2.39 2.15 2.38 2.61 2.16
Enterprise Value to Revenue (EV/Rev)
3.24 3.61 3.84 3.29 3.57 3.08 2.78 2.56 2.83 3.17 2.55
Enterprise Value to EBITDA (EV/EBITDA)
15.36 16.70 17.78 15.04 16.65 13.84 12.63 12.07 13.17 14.98 12.10
Enterprise Value to EBIT (EV/EBIT)
24.67 25.78 27.56 23.21 25.60 20.69 18.93 18.37 19.88 22.65 18.33
Enterprise Value to NOPAT (EV/NOPAT)
31.80 29.44 30.43 26.08 27.95 26.28 24.27 22.80 25.50 28.13 22.82
Enterprise Value to Operating Cash Flow (EV/OCF)
24.52 25.20 25.67 20.42 21.21 17.46 15.61 15.35 16.05 19.47 15.66
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 65.17 49.51 28.83 39.07 23.46 24.47 36.95 33.49 0.00 148.90
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.35 2.24 2.13 1.97 1.94 2.30 2.39 2.68 2.38 2.37 2.49
Long-Term Debt to Equity
2.12 2.12 2.02 1.80 1.76 2.12 2.19 2.45 2.03 2.09 2.20
Financial Leverage
2.06 1.95 1.88 1.88 1.85 1.95 1.93 1.94 1.82 1.96 2.06
Leverage Ratio
4.50 4.38 4.26 4.21 4.16 4.40 4.37 4.40 4.22 4.48 4.62
Compound Leverage Factor
3.04 2.98 2.93 3.13 2.87 3.40 2.94 2.87 2.95 3.33 2.97
Debt to Total Capital
70.13% 69.11% 68.09% 66.38% 65.98% 69.74% 70.54% 72.81% 70.40% 70.34% 71.38%
Short-Term Debt to Total Capital
6.73% 3.63% 3.61% 5.84% 5.95% 5.71% 6.02% 6.17% 10.19% 8.23% 8.31%
Long-Term Debt to Total Capital
63.40% 65.48% 64.48% 60.54% 60.03% 64.03% 64.52% 66.63% 60.22% 62.11% 63.06%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.04% 0.60% 0.57% 0.58%
Common Equity to Total Capital
29.87% 30.89% 31.91% 33.62% 34.02% 30.26% 29.42% 27.16% 29.00% 29.09% 28.05%
Debt to EBITDA
4.35 4.21 4.16 4.00 4.11 4.08 4.20 4.65 4.38 4.56 4.52
Net Debt to EBITDA
3.86 3.68 3.60 3.41 3.50 3.43 3.54 3.87 3.68 3.81 3.79
Long-Term Debt to EBITDA
3.93 3.99 3.94 3.65 3.74 3.75 3.84 4.26 3.75 4.03 4.00
Debt to NOPAT
9.01 7.43 7.12 6.94 6.91 7.75 8.07 8.79 8.48 8.56 8.53
Net Debt to NOPAT
7.99 6.49 6.15 5.91 5.87 6.52 6.79 7.32 7.13 7.16 7.16
Long-Term Debt to NOPAT
8.14 7.04 6.74 6.33 6.28 7.11 7.38 8.05 7.25 7.56 7.54
Altman Z-Score
1.87 2.07 2.22 2.06 2.14 1.95 1.77 1.59 1.72 1.88 1.64
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.06% 0.97% 1.00% 1.10%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.79 0.86 0.88 0.85 0.81 0.84 0.82 0.84 0.70 0.75 0.75
Quick Ratio
0.69 0.75 0.78 0.75 0.70 0.73 0.72 0.73 0.62 0.66 0.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,250 -371 -300 249 -109 714 388 -257 29 -1,390 -1,149
Operating Cash Flow to CapEx
399.32% 417.32% 360.00% 411.19% 480.67% 539.63% 400.00% 293.38% 1,488.52% 422.41% 486.61%
Free Cash Flow to Firm to Interest Expense
-6.91 -1.98 -1.81 1.52 -0.64 4.18 2.30 -1.41 0.15 -7.13 -5.99
Operating Cash Flow to Interest Expense
3.22 3.99 3.14 3.61 4.24 5.18 3.36 2.43 4.80 3.77 3.22
Operating Cash Flow Less CapEx to Interest Expense
2.41 3.04 2.27 2.73 3.36 4.22 2.52 1.60 4.48 2.88 2.56
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.59 0.58 0.58 0.58 0.58 0.58 0.58 0.57 0.57 0.57 0.58
Accounts Receivable Turnover
5.06 4.76 4.64 4.74 4.77 4.68 4.63 4.76 4.92 4.94 5.03
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
29.56 28.41 29.18 29.92 30.30 29.12 29.63 30.22 30.64 30.54 31.71
Accounts Payable Turnover
3.17 2.83 2.97 3.11 3.02 2.77 2.88 3.08 3.02 2.93 3.10
Days Sales Outstanding (DSO)
72.08 76.71 78.59 77.00 76.54 78.01 78.83 76.71 74.19 73.90 72.57
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
115.15 128.85 122.98 117.26 120.72 131.88 126.53 118.66 121.02 124.71 117.87
Cash Conversion Cycle (CCC)
-43.07 -52.14 -44.40 -40.27 -44.18 -53.87 -47.69 -41.95 -46.83 -50.82 -45.29
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
17,890 18,050 18,042 18,007 18,447 17,833 18,056 18,682 18,868 19,781 19,627
Invested Capital Turnover
0.87 0.85 0.85 0.85 0.84 0.86 0.86 0.86 0.85 0.87 0.88
Increase / (Decrease) in Invested Capital
1,661 1,009 733 182 557 -217 14 675 421 1,948 1,571
Enterprise Value (EV)
48,114 54,165 57,850 49,817 54,680 47,433 43,125 40,167 44,998 51,665 42,347
Market Capitalization
36,029 42,227 46,152 38,524 43,200 35,667 31,046 27,263 32,290 38,387 28,941
Book Value per Share
$31.70 $33.49 $34.88 $36.85 $38.22 $33.43 $33.94 $33.40 $36.24 $38.19 $36.66
Tangible Book Value per Share
($73.12) ($72.84) ($70.90) ($67.90) ($70.53) ($72.41) ($76.96) ($83.40) ($85.26) ($88.52) ($89.13)
Total Capital
19,436 19,785 19,880 19,972 20,479 20,050 20,315 21,276 21,245 22,354 22,182
Total Debt
13,631 13,673 13,536 13,258 13,512 13,983 14,330 15,490 14,957 15,724 15,833
Total Long-Term Debt
12,322 12,955 12,819 12,091 12,293 12,838 13,108 14,177 12,793 13,884 13,989
Net Debt
12,085 11,938 11,698 11,293 11,480 11,766 12,071 12,896 12,580 13,151 13,278
Capital Expenditures (CapEx)
146 179 145 143 150 164 142 151 61 174 127
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,404 -1,673 -1,655 -1,509 -1,853 -1,826 -1,922 -2,102 -2,337 -2,390 -2,368
Debt-free Net Working Capital (DFNWC)
-72 -177 -80 169 -141 17 -46 86 -365 -249 -265
Net Working Capital (NWC)
-1,381 -895 -797 -998 -1,360 -1,128 -1,268 -1,227 -2,529 -2,089 -2,109
Net Nonoperating Expense (NNE)
108 169 145 68 163 60 153 152 118 44 147
Net Nonoperating Obligations (NNO)
12,085 11,938 11,698 11,293 11,480 11,766 12,071 12,896 12,580 13,151 13,278
Total Depreciation and Amortization (D&A)
302 321 269 275 283 308 270 282 292 323 294
Debt-free, Cash-free Net Working Capital to Revenue
-9.45% -11.17% -10.98% -9.96% -12.10% -11.85% -12.40% -13.39% -14.69% -14.65% -14.24%
Debt-free Net Working Capital to Revenue
-0.48% -1.18% -0.53% 1.12% -0.92% 0.11% -0.30% 0.55% -2.30% -1.53% -1.59%
Net Working Capital to Revenue
-9.30% -5.97% -5.29% -6.59% -8.88% -7.32% -8.18% -7.82% -15.90% -12.81% -12.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.66 $2.56 $1.58 $1.99 $1.57 $2.43 $1.42 $1.55 $1.94 $3.00 $1.63
Adjusted Weighted Average Basic Shares Outstanding
182.90M 183.80M 181.90M 182.20M 182.10M 181.30M 175.70M 171.80M 170.20M 171.90M 168.40M
Adjusted Diluted Earnings per Share
$1.63 $2.54 $1.56 $1.97 $1.55 $2.41 $1.40 $1.54 $1.93 $2.97 $1.61
Adjusted Weighted Average Diluted Shares Outstanding
185.50M 186.30M 184.30M 184.30M 184.20M 183.40M 177.40M 173.20M 171.70M 173.50M 169.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
182.50M 181.50M 182.20M 182.30M 181.50M 176.10M 173M 170M 170.30M 169.70M 166.90M
Normalized Net Operating Profit after Tax (NOPAT)
436 363 446 454 470 494 426 445 466 579 463
Normalized NOPAT Margin
11.68% 9.37% 11.93% 11.90% 12.07% 12.48% 11.12% 11.07% 11.37% 13.28% 11.16%
Pre Tax Income Margin
9.34% 9.64% 9.10% 11.43% 8.96% 13.74% 8.44% 8.04% 9.95% 12.31% 7.90%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.85 2.93 2.98 3.60 2.98 4.12 2.85 2.72 3.09 3.70 2.66
NOPAT to Interest Expense
2.27 3.41 2.61 2.64 2.63 2.91 2.38 2.30 2.38 2.86 2.20
EBIT Less CapEx to Interest Expense
2.04 1.97 2.11 2.72 2.09 3.16 2.01 1.89 2.77 2.81 1.99
NOPAT Less CapEx to Interest Expense
1.46 2.45 1.74 1.76 1.75 1.95 1.54 1.47 2.06 1.97 1.53
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
74.19% 73.05% 63.60% 26.21% 30.53% 98.32% 129.31% 192.56% 169.94% 91.40% 102.45%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, four-year look at IQVIA (NYSE: IQV) focusing on trends in revenue, profitability, cash flow, and balance sheet metrics. The bullets highlight what may positively or negatively influence the stock, with positive items shown first, then neutral, then negative.

  • Revenue growth in Q4 2025: Operating revenue rose to $4.364B, up from $3.958B in Q4 2024 (about +10% YoY).
  • Earnings per share momentum: Diluted EPS in Q4 2025 was $2.97, up from $2.41 in Q4 2024.
  • Net income growth: Net income attributable to common shareholders reached $514M in Q4 2025, up from $437M in the year-ago period.
  • Solid free cash flow in Q4 2025: Free cash flow around $561M (CFO of $735M minus capex of $174M), indicating strong cash efficiency.
  • Margin dynamics: Gross margin declined to about 32.9% in Q4 2025 from roughly 34.8% in Q4 2024, suggesting margin compression.
  • Capex intensity: Capital expenditures were around $174M in Q4 2025, indicating steady but not aggressive investment in fixed assets.
  • Financing activity and liquidity signals: Debt issuance of about $4.48B and a net financing cash flow of roughly $0.54B imply greater leverage but provide liquidity headroom.
  • High leverage burden: Long-term debt around $12.79B and total liabilities near $22.44B, with cash around $1.81B, signaling a substantial net debt load.
  • Liquidity pressure on the balance sheet: As of mid-2025, current assets were about $5.98B versus current liabilities of $8.51B (roughly a 0.7x current ratio), indicating weaker near-term liquidity.
  • Investing cash outflows: Net cash from investing activities was about -$1.10B in Q4 2025, reflecting ongoing capital deployment and acquisitions.
05/14/26 05:08 PM ETAI Generated. May Contain Errors.

IQVIA Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IQVIA's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

IQVIA's net income appears to be on an upward trend, with a most recent value of $1.36 billion in 2025, rising from $388 million in 2015. The previous period was $1.37 billion in 2024. View IQVIA's forecast to see where analysts expect IQVIA to go next.

IQVIA's total operating income in 2025 was $2.18 billion, based on the following breakdown:
  • Total Gross Profit: $5.43 billion
  • Total Operating Expenses: $3.25 billion

Over the last 10 years, IQVIA's total revenue changed from $5.74 billion in 2015 to $16.31 billion in 2025, a change of 184.3%.

IQVIA's total liabilities were at $23.31 billion at the end of 2025, a 11.9% increase from 2024, and a 447.0% increase since 2015.

In the past 10 years, IQVIA's cash and equivalents has ranged from $837 million in 2019 to $1.98 billion in 2025, and is currently $1.98 billion as of their latest financial filing in 2025.

Over the last 10 years, IQVIA's book value per share changed from -4.58 in 2015 to 38.19 in 2025, a change of -933.4%.



Financial statements for NYSE:IQV last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners